Clinical Trials
2 trialsNCT06235918 2024-02-01
Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma
Tongji Hospital
Phase 2 Unknown
NCT04826679 2021-04-01
Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC
Sun Yat-sen University
Phase 2 Unknown